Drug treatment for hypertension
271 results
101 - 200
Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension: Cochrane systematic review
Health gains from the treatment of obesity 
Catheter ablation marginally better than usual care for symptomatic atrial fibrillation (CABANA)- Endothelin receptor antagonists for pulmonary arterial hypertension
- Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia
- 24-hour ambulatory blood pressure readings: more informative for the risks of all-cause and cardiovascular mortality
- First‐line diuretics versus other classes of antihypertensive drugs for hypertension
- Blood pressure‐lowering efficacy of reserpine for primary hypertension
- Good reasons not to lower the definition of high blood pressure in adults
- Oral antidiabetic drugs and GLP-1 analogues
- Regular long‐term red blood cell transfusions for managing chronic chest complications in sickle cell disease
- Higher blood pressure targets for hypertension in older adults
- Interventions used to improve control of blood pressure in patients with hypertension: Cochrane systematic review
- Statins for aortic valve stenosis
- Pharmacological interventions for hypertensive emergencies
- Medical interventions for primary open angle glaucoma and ocular hypertension
- Guanylate cyclase stimulators for pulmonary hypertension
- Alcohol or drug intoxication
- Long‐term effects of weight‐reducing drugs in people with hypertension
- Magnesium supplementation for the management of primary hypertension in adults
- Primary sclerosing cholangitis
- Effect of antihypertensive drugs on mortality, morbidity and blood pressure in blacks: Cochrane systematic review
- First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension: Cochrane systematic review
- Spironolactone most effective add-on for patients with resistant hypertension (PATHWAY-2)
- Alcoholic liver disease (ALD)
- Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals
- Blood pressure lowering efficacy of beta‐1 selective beta blockers for primary hypertension
- JNC 8 report on prevention/evaluation/treatment of hypertension
- Warfarin therapy
- Tight control no different from less-tight control of hypertension in pregnancy
- Acupuncture for hypertension
- Pharmacotherapy for hypertension in adults 60 years or older
- Blood pressure targets for hypertension in people with diabetes mellitus: Cochrane systematic review
- Adrenergic drugs for urinary incontinence in adults: Cochrane systematic review
- Blood pressure-lowering efficacy of loop diuretics for primary hypertension: Cochrane systematic review
- Pharmacotherapy for hypertension‐induced left ventricular hypertrophy
- One-third of people eligible for weight loss drugs are not represented in clinical research
- Acute coronary syndrome
- Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension: Cochrane systematic review
- Diabetic kidney disease (diabetic nephropathy)
- Hypertension in elderly patients
- Cardioselective beta‐blockers for chronic obstructive pulmonary disease
- First-line beta-blockers versus other antihypertensive medications for chronic type B aortic dissection: Cochrane systematic review
- Elevated blood pressure in pregnancy (gestational hypertension, pre-eclampsia)
- Choice of antihypertensive drug in the diabetic patient from prognostic point of view
- Identification of illegal drug overdose and diagnosis of illegal drug poisoning
- Safe use of non-steroidal anti-inflammatory drugs (NSAIDs)
- Creatine and creatine analogues in hypertension and cardiovascular disease
- Interventions for preventing and managing advanced liver disease in cystic fibrosis
- Endovascular denervation lowers blood pressure (RADIANCE-HTN SOLO)
- Drugs for preventing red blood cell dehydration in people with sickle cell disease
- Conservative (non-surgical) treatment of obesity
- Time course for blood pressure lowering of beta‐blockers with partial agonist activity
- Blood pressure lowering efficacy of nonselective beta-blockers for primary hypertension: Cochrane systematic review
- HIV infection
- Chronic heart failure
- Cardioselective beta‐blockers for reversible airway disease
- Increased pulmonary blood pressure: pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
- Withdrawal of antihypertensive drugs in older people
- Interventions for deliberately altering blood pressure in acute stroke
- Raynaud's phenomenon (RP) or white finger disease
- BP lowering by any means is beneficial in most
- Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease
- Evening versus morning dosing regimen drug therapy for hypertension
- Time course for blood pressure lowering of dihydropyridine calcium channel blockers: Cochrane systematic review
- Vericiguat for heart failure reduces hospitalization, but not mortality
- Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer
- Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients
- Antihypertensive therapy beneficial for patients with BP < 140/90 and history of CVD
- Pimavanserin of uncertain benefit to treat psychosis in patients with dementia
- Liraglutide produces modest weight loss and lots of side effects at a high cost
- Lower limb ischaemia
- Drug therapy for obstructive sleep apnoea in adults
- Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants
- Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
- Pharmacological interventions for hypertensive emergencies
- Drug interventions for the treatment of obesity in children and adolescents
- Systemic lupus erythematosus (SLE)
- Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia
- High-dose barium enemas prevent recurrent diverticular bleeding
- Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection
- Antenatal clinics and specialist care: consultations, referrals, treatment guidelines
- Drugs for treatment of very high blood pressure during pregnancy
- Prevention of atrial fibrillation
- Erythropoiesis‐stimulating agents for anaemia in adults with chronic kidney disease: a network meta‐analysis
- Erectile dysfunction
- Acute kidney injury
- Dieting to reduce body weight for controlling hypertension in adults: Cochrane systematic review
- 17-OHPC may not reduce recurrent preterm birth or decrease neonatal morbidity
- Propionyl‐L‐carnitine for intermittent claudication
- Similar risk of major malformations in infants of asthmatic women with alternate treatment regimens
- Sulodexide given long-term may reduce recurrent VTE in patients with initial unprovoked VTE
- Glyburide not beneficial for women with mild gestational diabetes
- Urinary incontinence in the elderly
- IV iron improves symptoms in chronic heart failure patients with iron deficiency